214 related articles for article (PubMed ID: 10626776)
1. Delineating psychopathologic clusters within dysthymia: a study of 512 out-patients without major depression.
Serretti A; Jori MC; Casadei G; Ravizza L; Smeraldi E; Akiskal H
J Affect Disord; 1999 Nov; 56(1):17-25. PubMed ID: 10626776
[TBL] [Abstract][Full Text] [Related]
2. Disentangling dysthymia from major depressive disorder in suicide attempters' suicidality, comorbidity and symptomatology.
Holmstrand C; Engström G; Träskman-Bendz L
Nord J Psychiatry; 2008; 62(1):25-31. PubMed ID: 18389422
[TBL] [Abstract][Full Text] [Related]
3. The validity of dysthymia to predict clinical depressive symptoms as measured by the Hamilton Depression Scale at the 5-year follow-up of patients with first episode depression.
Bech P; Kessing LV; Bukh JD
Nord J Psychiatry; 2016 Nov; 70(8):563-6. PubMed ID: 27181030
[TBL] [Abstract][Full Text] [Related]
4. [Depressive symptomatology and sleep apnea syndrome].
Pochat MD; Ferber C; Lemoine P
Encephale; 1993; 19(6):601-7. PubMed ID: 12404778
[TBL] [Abstract][Full Text] [Related]
5. Rating dysthymia: an assessment of the construct and content validity of the Cornell Dysthymia Rating Scale.
Hellerstein DJ; Batchelder ST; Lee A; Borisovskaya M
J Affect Disord; 2002 Sep; 71(1-3):85-96. PubMed ID: 12167504
[TBL] [Abstract][Full Text] [Related]
6. Chronic, low-grade depression in a nonclinical sample: depressive personality or dysthymia?
Ryder AG; Bagby RM; Dion KL
J Pers Disord; 2001 Feb; 15(1):84-93. PubMed ID: 11236817
[TBL] [Abstract][Full Text] [Related]
7. Dysthymia: clinical picture, extent of overlap with chronic fatigue syndrome, neuropharmacological considerations, and new therapeutic vistas.
Brunello N; Akiskal H; Boyer P; Gessa GL; Howland RH; Langer SZ; Mendlewicz J; Paes de Souza M; Placidi GF; Racagni G; Wessely S
J Affect Disord; 1999; 52(1-3):275-90. PubMed ID: 10357046
[TBL] [Abstract][Full Text] [Related]
8. Dysthymic disorder: clinical characteristics in relation to age at onset.
Barzega G; Maina G; Venturello S; Bogetto F
J Affect Disord; 2001 Sep; 66(1):39-46. PubMed ID: 11532531
[TBL] [Abstract][Full Text] [Related]
9. Phenomenology, psychosocial correlates, and treatment seeking in major depression and dysthymia of adolescence.
Flament MF; Cohen D; Choquet M; Jeammet P; Ledoux S
J Am Acad Child Adolesc Psychiatry; 2001 Sep; 40(9):1070-8. PubMed ID: 11556631
[TBL] [Abstract][Full Text] [Related]
10. Open-label evaluation of venlafaxine sustained release in outpatients with generalized anxiety disorder with comorbid major depression or dysthymia: effectiveness, tolerability and predictors of response.
Perugi G; Frare F; Toni C; Ruffolo G; Torti C
Neuropsychobiology; 2002; 46(3):145-9. PubMed ID: 12422062
[TBL] [Abstract][Full Text] [Related]
11. Major depression, double depression and personality disorders.
Kool S; Dekker J; Duijsens IJ; de Jonghe F
J Pers Disord; 2000; 14(3):274-81. PubMed ID: 11019750
[TBL] [Abstract][Full Text] [Related]
12. Childhood adversity and anxiety versus dysthymia co-morbidity in major depression.
Harkness KL; Wildes JE
Psychol Med; 2002 Oct; 32(7):1239-49. PubMed ID: 12420893
[TBL] [Abstract][Full Text] [Related]
13. The prevalence and severity of depressive symptoms along the spectrum of unipolar depressive disorders: a post hoc analysis.
Rakofsky JJ; Schettler PJ; Kinkead BL; Frank E; Judd LL; Kupfer DJ; Rush AJ; Thase ME; Yonkers KA; Rapaport MH
J Clin Psychiatry; 2013 Nov; 74(11):1084-91. PubMed ID: 24330894
[TBL] [Abstract][Full Text] [Related]
14. A validation study of depressive syndromes in Parkinson's disease.
Starkstein SE; Merello M; Jorge R; Brockman S; Bruce D; Petracca G; Robinson RG
Mov Disord; 2008 Mar; 23(4):538-46. PubMed ID: 18074376
[TBL] [Abstract][Full Text] [Related]
15. Is dysthymia a different disorder in the elderly?
Devanand DP; Nobler MS; Singer T; Kiersky JE; Turret N; Roose SP; Sackeim HA
Am J Psychiatry; 1994 Nov; 151(11):1592-9. PubMed ID: 7943446
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of major and minor depression in elderly persons with mild cognitive impairment--MADRS factor analysis.
Gabryelewicz T; Styczynska M; Pfeffer A; Wasiak B; Barczak A; Luczywek E; Androsiuk W; Barcikowska M
Int J Geriatr Psychiatry; 2004 Dec; 19(12):1168-72. PubMed ID: 15526303
[TBL] [Abstract][Full Text] [Related]
17. Quetiapine in the treatment of anxiety in patients with bipolar I or II depression: a secondary analysis from a randomized, double-blind, placebo-controlled study.
Hirschfeld RM; Weisler RH; Raines SR; Macfadden W;
J Clin Psychiatry; 2006 Mar; 67(3):355-62. PubMed ID: 16649820
[TBL] [Abstract][Full Text] [Related]
18. Phenomenology and comorbidity of dysthymic disorder in 100 consecutively referred children and adolescents: beyond DSM-IV.
Masi G; Millepiedi S; Mucci M; Pascale RR; Perugi G; Akiskal HS
Can J Psychiatry; 2003 Mar; 48(2):99-105. PubMed ID: 12655907
[TBL] [Abstract][Full Text] [Related]
19. [Symptoms of depression in children and adolescents in relation to psychiatric comorbidities].
Baji I; Gádoros J; Kiss E; Mayer L; Kovács E; Benák I; Vetró A
Psychiatr Hung; 2012; 27(2):115-26. PubMed ID: 22700622
[TBL] [Abstract][Full Text] [Related]
20. Treatment effects of selegiline transdermal system on symptoms of major depressive disorder: a meta-analysis of short-term, placebo-controlled, efficacy trials.
Robinson DS; Gilmor ML; Yang Y; Moonsammy G; Azzaro AJ; Oren DA; Campbell BJ
Psychopharmacol Bull; 2007; 40(3):15-28. PubMed ID: 18007565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
